A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML-Reference-Cited by-同舟云学术

A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML

Published:2024-06 Issue:6 Volume:5 Page:101592
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Guo He-Zhou,Feng Rui-Xue,Zhang Yan-Jie,Yu Ye-Hua,Lu Wei,Liu Jia-Jia,Yang Shao-Xin,Zhao Chong,Zhang Zhao-Li,Yu Shan-He,Jin Hui,Qian Si-Xuan,Li Jian-Yong,Zhu Jiang,Shi Jun

Publisher

Elsevier BV

Reference56 articles.

1. Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

2. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia;Kantarjian;J. Clin. Oncol.,2012

3. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia;DiNardo;N. Engl. J. Med.,2020

4. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia;Pollyea;Nat. Med.,2018

5. Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells;Jones;Cancer Cell,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and research progress of single cell sequencing technology in leukemia;Frontiers in Oncology;2024-08-29